A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-28) →
What happened
Paratech disclosed a supply contract with Lotte Biologics Co., Ltd., worth US$13.7M, about 12.25% of its recent annual revenue, running through Aug 2026.
For context, this single contract equals about 12.25% of the company's most recent annual revenue.
| Counterparty | Lotte Biologics Co., Ltd. |
|---|---|
| Contract value | US$13.7M |
| vs. recent revenue | 12.25% |
| Through | Aug 2026 (from Mar 2025) |
| Filed | 2026-07-01, Supply contract signed |
| Source | DART rcept 20260701900558 → open original filing |
Versions of this filing
- 2026-07-01Original (this page)
- 2026-08-28Amendment 1
Source: DART. Information only, not investment advice.